Overview
Hirokazu Iwamuro practices in Tokyo, Japan. Iwamuro is highly rated in 6 conditions, according to our data. Their top areas of expertise are Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, Deep Brain Stimulation, and Thalamotomy.
Their clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Deep Brain StimulationIwamuro isDistinguished. Learn about Deep Brain Stimulation.
- Movement DisordersIwamuro isDistinguished. Learn about Movement Disorders.
- Parkinson's DiseaseIwamuro isDistinguished. Learn about Parkinson's Disease.
- Advanced
- Drug Induced DyskinesiaIwamuro isAdvanced. Learn about Drug Induced Dyskinesia.
- Multiple System AtrophyIwamuro isAdvanced. Learn about Multiple System Atrophy.
- ThalamotomyIwamuro isAdvanced. Learn about Thalamotomy.
- Experienced
- DysarthriaIwamuro isExperienced. Learn about Dysarthria.
- EpendymomaIwamuro isExperienced. Learn about Ependymoma.
- Essential TremorIwamuro isExperienced. Learn about Essential Tremor.
- Familial DysautonomiaIwamuro isExperienced. Learn about Familial Dysautonomia.
- Neurotoxicity SyndromesIwamuro isExperienced. Learn about Neurotoxicity Syndromes.
- Primary Lateral SclerosisIwamuro isExperienced. Learn about Primary Lateral Sclerosis.